Home›Companies›Biotech & Pharma›Paralos

Paralos Bioscience Inc.

Makes custom phage preparations for researchers testing proteins and other molecular designs.

Updated Nov 10, 2026·Latest SEC filing Jun 23, 2026·Suggest an edit

About Paralos

Paralos is a private company based in Los Angeles, California, incorporated in 2024 in Delaware. It has reported $646,900 raised in one offering on Form D since August 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 28, 2025Aug 7, 2025amended Jun 23, 2026$646,900of $1.0M target5$129KEquity, DebtRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Paralos's Form D filed Jun 23, 2026.

IC
Irene Chen
President and director
YY
Yanxi Yang
Executive officer

Sources

  1. SECParalos Bioscience Inc. Form D/A, filed Apr 17, 2026
  2. SECParalos Bioscience Inc. Form D/A, filed Sep 24, 2025
  3. SECParalos Bioscience Inc. Form D, filed Aug 7, 2025
  4. SECParalos Bioscience Inc. filing history
  5. CompanyContact
  6. CompanyPrivacy policy